CIK 0001359931
- Non-accelerated filer
- Smaller reporting company
Protara Therapeutics, Inc.
Sign in to watch- Ticker
- TARA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 204580525
- Phone
- +1 646-844-0337
- Business address
- 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
- Former names
- Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 31 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-31 | Kowalsky Matthew Paul VP, Legal and Secretary | Grant or award | +2,448 | $1.93 | $5K | 29,479 |
| 2018-12-31 | Eldridge, George Arthur Sr VP, CFO, Treasr, Asst Secy | Grant or award | +2,448 | $1.93 | $5K | 29,132 |
| 2018-12-31 | Burke Steven Keith SVP and Chief Medical Officer | Grant or award | +2,448 | $1.93 | $5K | 123,917 |
| 2018-08-01 | Hartman Bradley J VP, People | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2018-06-29 | Toner E. Scott Senior VP of Commercial | Grant or award | +4,856 | $1.62 | $8K | 19,240 |
| 2018-06-29 | Kowalsky Matthew Paul VP, Legal and Secretary | Grant or award | +10,000 | $1.62 | $16K | 27,031 |
| 2018-06-29 | Eldridge, George Arthur Sr VP, CFO, Treasr, Asst Secy | Grant or award | +10,000 | $1.62 | $16K | 26,684 |
| 2018-06-29 | Burke Steven Keith SVP and Chief Medical Officer | Grant or award | −10,000 | $1.62 | $16K | 121,469 |
| 2018-06-08 | LEFF JONATHAN S Director | Grant or award · Stock Option (Right to Buy) | +12,700 | 12,700 | ||
| 2018-06-08 | Flynn James E Director | Grant or award · Stock Option (Right to Buy) | +12,700 | 12,700 | ||
| 2018-06-08 | Kingsley Stuart A Director | Grant or award · Stock Option (Right to Buy) | +12,700 | 12,700 | ||
| 2018-06-08 | HASTINGS PAUL J Director | Grant or award · Stock Option (Right to Buy) | +12,700 | 12,700 | ||
| 2018-06-08 | Haines Timothy Director | Grant or award · Stock Option (Right to Buy) | +12,700 | 12,700 | ||
| 2018-06-08 | Freund John Gordon Director | Grant or award · Stock Option (Right to Buy) | +12,700 | 12,700 | ||
| 2018-06-08 | Canute Scott A Director | Grant or award · Stock Option (Right to Buy) | +12,700 | 12,700 | ||
| 2018-06-08 | BOHLIN GAREN G Director | Grant or award · Stock Option (Right to Buy) | +12,700 | 12,700 | ||
| 2018-06-08 | Birner Hubert Director | Grant or award · Stock Option (Right to Buy) | +12,700 | 12,700 | ||
| 2018-06-08 | Abingworth LLP 10% owner | Grant or award · Stock Option (Right to Buy) | +12,700 | 12,700 | ||
| 2018-02-16 | NOYES TIMOTHY P President and CEO | Returned to the company | −2,997 | $2.11 | $6K | 0 |
| 2018-02-15 | NOYES TIMOTHY P President and CEO | Returned to the company | −2,245 | $2.15 | $5K | 2,997 |
Page 19 of 24 · 473 trades